Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer

Journal of Infectious Diseases

Volumn 180, Issue 5, 1999, Pages 1415-1423

  Franco, Eduardo L ^a   Villa, Luisa L ^c   Sobrinho, Joao P ^c   Prado, José M ^c   Rousseau, Marie Claude ^a   Désy, Marie ^b   Rohan, Thomas E ^d  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLEARANCE; CONDYLOMA; DISEASE DURATION; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; INCIDENCE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; WART VIRUS;

ADULT; AGE DISTRIBUTION; BRAZIL; CERVIX UTERI; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DISEASES; UTERINE CERVICAL NEOPLASMS;

EID: 0032730126     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315086     Document Type: Article

References (24)

1. 1. IARC Working Group. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 1995;64:279-82.
2. 2. Schiffman MH, Burk RD. Human papillomaviruses. In: Evans A, Kaslow R, eds. Viral infections of humans, epidemiology and control, Part III. Viral infections and malignant diseases, New York; Plenum, 1997; 983-1023.
3. 3. Franco EL, Villa LL, Richardson H, Rohan T, Ferenezy A. Epidemiology of cervical human papillomavirus infection. In: Franco EL, Monsonego J, eds. New developments in cervical cancer screening and prevention. Oxford, UK: Blackwell Science, 1997:14-22.
4. 4. Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer 1995;76:1888-901.
5. 5. Moscicki AB, Palefsky J, Smith G, Siboshski S, Schoolnik G. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol 1993;82:578-85.
6. 6. Hildesheim A, Schiffman MH, Gravitt PE, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-40.
7. 7. Hinchliffe SA, VanVelzen D, Korporaal H, Kok PL, Boon ME. Transience of cervical HPV infection in sexually active young women with normal cervicovaginal cytology. Br J Cancer 1995;72:943-5.
8. 8. Ho GY, Bierman R, Beardsley L, Chang CJ, Murk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.
9. 9. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-8.
10. 10. Ho GYF, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-71.
11. 11. Johnson K. Periodic health examination, 1995 update 1: screening for human papillomavirus infection in asymptomatic women. Canadian Task Force on the Periodic Health Examination. Can Med Assoc J 1995;152:483-93.
12. 12. Richart RM. Screening the next century. Cancer 1995;76:1919-27.
13. 13. Jenkins D, Sherlawjohnson C, Gallivan S. Can papilloma virus testing be used to improve cervical cancer screening. Int J Cancer 1996;65:768-73.
14. 14. Franco EL, Villa L, Rohan T, et al. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Pan Am J Publ Health (in press).
15. 15. Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991;265:472-7.
16. 16. Bernard HU, Chan SY, Manos MM, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994;170:1077-85; erratum 1996;173:516.
17. 17. Bauer HM, Hildesheim A, Schiffman MH, et al. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 1993;20:274-8.
18. 18. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents. Vol VII. Lyon, France: IARC Scientific Publications (no. 143), 1997:1012-3.
19. 19. Moscicki AB, Shiboski S, Broering J, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998;132:277-84.
20. 20. Evander M, Edlund K, Gustafsson A, et al. Human papillomavirus infection is transient in young women a population-based cohort study. J Infect Dis 1995;171:1026-30.
21. 21. Hildesheim A, Gravitt P, Schiffman MH, et al. Determinants of genital human papillomavirus infection in low-income women in Washington, DC. Sex Transm Dis 1993;20:279-85.
22. 22. Karlsson R, Jonsson M, Edlund K, et al. Lifetime number of partners as the only independent risk factor for human papillomavirus infection-a population-based study. Sex Transm Dis 1995;22:119-27.
23. 23. Franco EL, Villa LL, Ruiz A, Costa MC. Transmission of cervical human papillomavirus infection by sexual activity: differences between low-and high-risk oncogenic types. J Infect Dis 1995;172:756-63.
24. 24. Freeman J, Hutchison GB. Prevalence, incidence and duration. Am J Epidemiol 1980;112:707-23.